LONDON (ShareCast) - (Sharecast News) - Specialist wound care company Advanced Medical Solutions Group has received CE-mark approval for its 'Silicone PHMB Foam Dressing', it announced on Friday, which sits alongside the US approval for this product as announced in July 2019 .
The AIM-traded firm said the product would be commercialised via its network of wound care partners and distributors in CE-mark markets.

It described the PHMB Foam Dressing as a polyurethane foam impregnated with polyhexamethylene biguanide, along with an atraumatic perforated silicone wound contact layer.

The dressing was indicated for use in the management of various wounds including pressure sores, diabetic ulcers, post-op surgical wounds and burns.

It said the product could manage wound exudate as well as microbial contamination, with the atraumatic silicone layer reducing wound pain during healing and dressing changes.

The dressing had been shown to be highly effective against methicillin-resistant staphylococcus aureus (MRSA) and a "broad spectrum" of microbes, with in vitro testing demonstrating total eradication of MRSA, MRSE, and E. coli within 24 hours, compared to market-leading silver products which failed to achieve that within seven days.

"This new product approval in Europe for Silicone PHMB Foam Dressing further strengthens AMS's advanced wound care portfolio in Europe and reinforces the fact that our research and development and regulatory capabilities are a key pillar of our organic growth strategy," said chief executive officer Chris Meredith.

At 15490 GMT, shares in Advanced Medical Solutions Group were down 0.22% at 230p.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE